E
An early-stage biotechnology company specializing in RNA editing technology, focusing on precise modifications to RNA sequences to enhance gene expression and therapeutic outcomes. The company aims to address genetic disorders by providing targeted solutions that improve the efficacy of RNA-based treatments.
Updated 2 months ago
Funding
Funding not disclosed
S
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- An early-stage biotechnology company specializing in RNA editing technology, focusing on precise modifications to RNA sequences to enhance gene expression and therapeutic outcomes. The company aims to address genetic disorders by providing targeted solutions that improve the efficacy of RNA-based treatments.